COMBIOXIN SA has a total of 21 patent applications. It decreased the IP activity by 20.0%. Its first patent ever was published in 2017. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals, environmental technology and medical technology are HANANJA EHF, BIOENVISION INC and FAULK PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | China | 3 | |
#4 | United States | 3 | |
#5 | Australia | 2 | |
#6 | Canada | 2 | |
#7 | Hungary | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Serbia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Climate change adaptation technologies | |
#4 | Object sterilising |
# | Name | Total Patents |
---|---|---|
#1 | Azeredo Da Silveira Lajaunias Samareh | 21 |
#2 | Lajaunias Frédéric | 14 |
#3 | Lajaunias Frederic | 7 |
Publication | Filing date | Title |
---|---|---|
EP3781210A1 | Treatment of sepsis and septic shock | |
CN112004540A | Treatment of pneumonia | |
EP3589278A1 | Liposomes for inhibiting biofilm formation | |
EP3471732A1 | Liposomes for the treatment of viral infections |